The Scientist

» regulation

Most Recent

image: Chair of Chemical Safety Board to Step Down

Chair of Chemical Safety Board to Step Down

By Ashley Yeager | May 25, 2018

Vanessa Allen Sutherland will resign next month, leaving the agency with just three members of what should be a five-person board.

1 Comment

image: USDA Will Not Regulate CRISPR-Edited Crops

USDA Will Not Regulate CRISPR-Edited Crops

By Diana Kwon | April 2, 2018

Restrictions will remain on transgenic plants, which contain artificially inserted genes from other species.

0 Comments

An analysis of 49 patient samples finds high proportions of false positives and misinterpretation.

0 Comments

image: Tadpoles Keep Eating Because They Don’t Feel Full

Tadpoles Keep Eating Because They Don’t Feel Full

By Catherine Offord | March 28, 2018

Baby frogs don’t develop the neural circuitry responsible for feeding inhibition until they begin metamorphosing into adults. 

0 Comments

Rather, the breast cancer mutation screen was classified as a type of medical device with obligations for the company to reduce risks to customers.

1 Comment

The findings of an official report come a month after a German court ruled in favor of banning diesel cars.

0 Comments

image: New Automated Tool Monitors Clinical Trial Reporting

New Automated Tool Monitors Clinical Trial Reporting

By Diana Kwon | February 22, 2018

The watchdog website FDAAA TrialsTracker names and shames human studies that breach the FDA’s requirements for reporting results.

0 Comments

image: How Toxic is the World’s Most Popular Herbicide Roundup?

How Toxic is the World’s Most Popular Herbicide Roundup?

By Katarina Zimmer | February 7, 2018

Glyphosate, the active ingredient in Roundup, is designed to be toxic to plants, but scientists observe some untoward effects on animals in the lab. 

10 Comments

image: EU Advisor Recommends Regulatory Exemption for Gene Editing

EU Advisor Recommends Regulatory Exemption for Gene Editing

By Catherine Offord | January 19, 2018

Crops produced using mutagenic technologies such as CRISPR should generally be exempt from regulatory laws governing GMOs, according to the published opinion.

0 Comments

More than 200 people are on waiting lists for the $373,000 treatment as hospitals try to work around problems with insurers. 

0 Comments

Popular Now

  1. Prominent Salk Institute Scientist Inder Verma Resigns
  2. Anheuser-Busch Won’t Fund Controversial NIH Alcohol Study
  3. North American Universities Increasingly Cancel Publisher Packages
  4. CRISPR Efficiency Tied to Cancer-Causing Process